500 Boylston Street, Boston, MA 02116 617-419-4700
Return to Results
The primary objective of the study is to assess the diagnostic efficacy (specificity and
sensitivity) of flurpiridaz F18 injection PET myocardial perfusion imaging (MPI) compared to
single photon emission computed tomography (SPECT) MPI in the detection of significant
coronary artery disease (CAD) as defined by invasive coronary angiography (ICA) or a
documented history of Myocardial Infarction (MI).
Ages:18 and older
Inclusion Criteria: Invasive Coronary Angiography. Men or Women age 18 or older - see protocol for additional details. Exclusion Criteria: Women who are pregnant, lactating, or of child bearing potential who are not practicing birth control. Unstable cardiac status. History of coronary artery bypass graft. History of PCI within the past six months. See protocol for additional details.
Sponsor: Lantheus Medical Imaging
Phase: Phase 3
Trial ID: NCT01347710
Not Accepting Healthy Volunteers